Poulenc to form Aventis; Zeneca has merged with Astia; Dupont has bought up Pioneer HiBred; and Monsanto now owns Cargill Seeds, DeKalb, Calgene, Agracetus, Delta and Pine Land, Holden and Asgrow, Seminis. Eighty percent of all genetically engineered seeds planted are Monsanto's "intellectual property." And Monsanto owns broad species patents on cotton, mustard, soyabean -crops that were not "invented" or "created" by Monsanto but have been evolved over centuries of innovation by farmers of India and East Asia working in close partnership with biodiversity gifted by nature.
There are three perversions inherent in patents on living material:
ETHICAL PERVERSION
This refers to the claim that seeds, plants, sheep, cows or human cell lines are nothing but "products of the mind" "created" by Monsanto, Novartis, Ian Wilmut or PPL. Living organisms have their intrinsic self-organization; they make themselves, and hence cannot be reduced to the status of "inventions"
and "creations" of patent holders. They cannot be "owned" as private property because they are our ecological kin, not just "genetic mines."
CRIMINALIZATION OF SAVING AND SHARING SEEDS
The recognition of corporations as "owners" or seed through intellectual property rights converts farmers into 'thieves" when they save seed or share it with neighbours. Monsanto hires detectives to chase farmers who might be engaging in such "theft".
ENCOURAGES BIOPIRACY
"Biopiracy" is the theft of biodiversity and indigenous knowledge through patents. Biopiracy deprives the South in three ways:
It creates a false claim to novelty and invention, even though the knowledge has evolved since ancient times. Thus, biopiracy is intellectual theft, which robs Third World people of their creativity and their intellectual resources.
It diverts scarce biological resources to monopoly control of corporations, depriving local communities and indigenous practitioners. Thus, biopiracy is resource theft from the poorest two thirds of humanity who depend on biodiversity for their livelihoods and basic needs.
It creates market monopolies and excludes the original innovators form their rightful share of local, national and international markets.
Instead of preventing this organized economic theft, WTO rules protect the powerful and punish the victims. In a dispute initiated by the United States against India, the WTO forced India to change its patent laws and grant exclusive marketing rights to foreign corporations on the basis of foreign patents. Since many of these patents are based on biopiracy, the WTO is in fact promoting piracy through patents.
Overtime, the consequences of TRIPs for the South's biodiversity and southern people's rights to their diversity will be severe. No one will be able to produce or reproduce patented agricultural, medicinal, or animal products freely, thus eroding livelihoods of small producers and preventing the poor from using their own resource and knowledge to meet their basic needs of health and nutrition. Royalties for their use will have to be paid to the patentees and unauthorized production will be penalized, thus increasing the debt burden.
The new IPR laws embodied in the TRIPS agreement of WTO have unleashed an epidemic of the piracy of nature's creativity and millennia of indigenous innovation. RFSTE / Navdanya started the campaign against biopiracy with Neem Campaign in 1994 and mobilized 1,00,000 signatures against neem patents and filed a legal opposition against the USDA and WR Grace patent on the fungicidal properties of neem (no. 436257 B1) The potential costs of biopiracy to the Third World poor are very high since two thirds of the people in the South depend on free access to biodiversity for their livelihoods and needs. Seventy percent of seed in India is saved or share farmers' seed; 70 percent of healing is based on indigenous medicine using local plants.
If a patent system that is supposed to reward inventiveness and creatively systematically reward piracy, if a patent system fails to honestly apply criteria of novelty and non-obviousness in the granting of patents related to indigenous knowledge, then the system is flawed, and it needs to change. It cannot be the basis of granting patents or establishing exclusive marketing rights. The problem of biopiracy is a result of Western-style IPR systems, not the absence of such IPR systems in India. Therefore, the implementation of TRIPs, which is based on the US style patent regimes, should be immediately stopped and its review started.
TRIPS allows rich countries to pirate knowledge freely from other countries, patent it, and then fiercely protect this stolen knowledge as "intellectual property". Knowledge flows freely from the South to the North through biopiracy but is prevented from flowing freely from the North to the South through patents. If biopiracy is to stop, then TRIPS change. Monsanto enjoys a monopoly on production, supply and marking of Bt.
SEED MONOPOLIES AND FARMERS SUICIDES IN INDIA
Cotton seed in India. The firm operates through its subsidiary -Mahyco. From the last few years, the company has been charging a 'trait value' (price fixed for research and development on Bt. Cotton seed, which can resist local pests) at Rs. 1750 per pack of 450 grams of seed.
The MNC gets the seed for Rs. 300 per pack of 750 grams from the farmers who grow it under the company's supervision. The Government has challenged the validity of the 'trait value' in the court and demanded its abolition.
The Government has also demanded Rs. 400 crore from the company, which it collected from the farmers.
The MRTPC directed the Mahyco-Monsanto to reduce the 'trait value' to a reasonable extent. The MNC tried to approach the Supreme Court to stay the order of the MRTPC. But the apex court refused to grant a stay. The act of the company in fixing the price of Rs. 880 exhibited its callousness and utter disregard to the commission order, the government said in its petition before the MRTPC. The government also asked the commission to initiate contempt proceedings against the company and its officials.
MONOPOLIES OVER MEDICINE
Not only has TRIPs encouraged monopolies over seed, threatening the very survival of farmers, it has also led to monopolies in medicine.
India's national laws did not allow products patents in medicine. Only new processes could be patented. Generic medicine for AIDS from India is available for $200 for a years treatment. It is this access to medicine that the global corporations are seeking to destroy to make super profits through monopolies.
On 6 th May 1982, Prime Minister Indira Gandhi, addressing the World Health Assembly in Geneva, said:
"Affluent societies are spending vast sums of money understandably on the search for new products and processes to alleviate suffering and to prolong life. In the process, drug manufacturers have become a powerful industry. My idea of a better ordered world is one in which medical discoveries would be free of patents and there would be no profiteering from life or death." Yet, instead of promoting access to seed for all farmers and access to medicines for all, the G-8 is promoting access to monopoly markets for those pharmaceutical giants, which are also the seed biotechnology giants.
THE G-8 IN SUPPORT TO IPR MONOPOLIES OF GLOBAL CORPORATIONS
The priorities for the G-8 submitted as identified by the Personal
Advisor to the Chancellor (Berlin, October 10, 2006) repeated refers to stronger IPR rights for corporations, and hence weaker rights to food and medicine for citizens. The note on priorities states, "Innovation is at the root of welfare in knowledge-based societies. Protection of innovation, especially in international trade and investment relations, plays a decisive role for the willingness to invest in research and development. We see a need for action particularly in the improvement of international cooperation to implement intellectual property rights in the fight against product and brand piracy."
There is no mention of biopiracy. Product patents are, assumed to be a right and process patents are defined as "product piracy". This is a trait support to corporate monopolies over seeds and medicines.
Instead of making a commitment to the outstanding review of TRIPs, the G-8 priority is to create new agreements to enforce monopolies for corporations.
"The ability of knowledge based societies to innovate is increasingly challenged by violations of intellectual property rights. In this context, the German G8 Presidency aims to bring the protection of innovation through international and domestic law onto the G8 agenda. Our particular attention goes to improving the implementation of intellectual property rights. However, we are primarily concerned with developing new initiatives within the G8 framework, for instance few international agreements that are necessary to solve problems with the implementation of existing national and international rules. In particular, we aim to initiate a structured dialogue with emerging countries about the protection of intellectual property. We assume that given the effort to develop their own technological innovations, these countries will also 
